For the Inventor, By the Inventor

Enter assignee name

Carlsbad, CA, United States of America

The Immune Response Corporation

USPTO Granted Patents = 33

Forward Citations = 638

Loading Chart...

Loading Chart...

32 inventors (with patents filed for the assignee):

Dennis J Carlo (20 out of 21 patents)

Steven W Brostoff (11 out of 12 patents)

Mark D Howell (9 out of 10 patents)

4. Jonas Salk (7 out of 7 patents)

5. Charles R Ill (3 out of 3 patents)

6. Scott Bidlingmaier (2 out of 2 patents)

7. William Soo Hoo (2 out of 2 patents)

8. Henry C Chiou (2 out of 2 patents)

9. Ronald B Luftig (2 out of 3 patents)

10. Christopher P Prior (2 out of 4 patents)

11. David M Weber (2 out of 2 patents)

12. Richard S Gore (2 out of 2 patents)

13. James J Harter (2 out of 2 patents)

14. Daniel P Gold (1 out of 10 patents)

15. Claire Q Yang (1 out of 1 patent)

33 patents: Sort by Forward Citations

1. 6737066 - HIV immunogenic compositions and methods (2004-05-18),

2. 6642028 - Vectors and genes exhibiting increased expression (2003-11-04),

3. 6557296 - Non-infectious, protease defective HIV particles and nucleic acid molecules encoding therefor (2003-05-06),

4. 6482407 - Membrane-bound cytokine compositions comprising GM-CSF or an active fragment thereof and methods of modulating and an immune response using the same (2002-11-19),

5. 6464978 - Vaccination and methods against multiple sclerosis resulting from pathogenic responses by specific T cell populations (2002-10-15),

6. 6413516 - Peptides and methods against psoriasis (2002-07-02),

7. 6331525 - Targeted delivery of genes encoding interferon (2001-12-18),

8. 6328976 - Non-infectious, protease defective HIV particles and nucleic acid molecules encoding therefor (2001-12-11),

9. 6221352 - Method of preventing the proliferation of V&bgr;14 or V&bgr;17-Expressing T cells (2001-04-24),

10. 6207645 - Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations (2001-03-27),

11. 6159470 - Vaccination and methods against diseases resulting from pathogenic (2000-12-12),

12. 6113903 - Peptides and methods against diabetes (2000-09-05),

13. 6090387 - Vaccination and methods against diseases resulting from pathogenic (2000-07-18),

14. 6080571 - Highly efficient production and isolation of viral particles utilizing (2000-06-27),

15. 6069133 - Targeted delivery of genes encoding interferon (2000-05-30),

The Immune Response Corporation is a biotechnology company that focuses on the development of innovative immunotherapies for treating HIV/AIDS and other infectious diseases. We aim to revolutionize the treatment and prevention of diseases by harnessing the power of the immune system. Through our cutting-edge research and collaborative partnerships, we strive to improve the lives of millions of people worldwide affected by these diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

33 Patents

#47 in Carlsbad, CA

#2,382 in California

#9,948 in US

#19,556 in the World

Carlsbad, CA, United States of America

The Immune Response Corporation

Forward Citations = 638

32 inventors:

Dennis J Carlo (20 out of 21 patents)

Steven W Brostoff (11 out of 12 patents)

Mark D Howell (9 out of 10 patents)

4. Jonas Salk (7 out of 7 patents)

5. Charles R Ill (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…